{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/regulatory-intelligence-action-transforming-compliance-strategy#webpage",
"url": "https://www.fortrea.com/insights/regulatory-intelligence-action-transforming-compliance-strategy",
"name": "Regulatory intelligence in action: Transforming compliance into strategy",
"description": "This Fortrea Case Study demonstrates how regulatory intelligence was integrated into pharmacovigilance operations to support global product commercialization, post-marketing surveillance and regulatory compliance across multiple international markets. Following approvals in the United States, Canada, Europe, Asia-Pacific and other regions, a commercial-stage biopharmaceutical company faced complex safety oversight requirements involving individual case safety report (ICSR) processing, literature surveillance, adverse event management and evolving regulatory obligations. Fortrea implemented an end-to-end pharmacovigilance solution that embedded regulatory intelligence directly into safety workflows, enabling rapid interpretation of regulatory updates, consistent compliance with country-specific reporting requirements and proactive management of regulatory risk. By aligning post-marketing surveillance activities with global safety reporting standards and integrating regulatory intelligence into daily operations, the program strengthened inspection readiness, improved operational efficiency and supported patient safety throughout the product lifecycle while helping the sponsor navigate a rapidly changing global regulatory environment. "
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Regulatory intelligence in action: Transforming compliance into strategy",
"item": "https://www.fortrea.com/insights/regulatory-intelligence-action-transforming-compliance-strategy"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/regulatory-intelligence-action-transforming-compliance-strategy#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/regulatory-intelligence-action-transforming-compliance-strategy#webpage"
},
"headline": "Regulatory Intelligence Through Integrated Pharmacovigilance and Global Safety Compliance | Fortrea Case Study",
"description": "This Fortrea Case Study demonstrates how regulatory intelligence was integrated into pharmacovigilance operations to support global product commercialization, post-marketing surveillance and regulatory compliance across multiple international markets. Following approvals in the United States, Canada, Europe, Asia-Pacific and other regions, a commercial-stage biopharmaceutical company faced complex safety oversight requirements involving individual case safety report (ICSR) processing, literature surveillance, adverse event management and evolving regulatory obligations. Fortrea implemented an end-to-end pharmacovigilance solution that embedded regulatory intelligence directly into safety workflows, enabling rapid interpretation of regulatory updates, consistent compliance with country-specific reporting requirements and proactive management of regulatory risk. By aligning post-marketing surveillance activities with global safety reporting standards and integrating regulatory intelligence into daily operations, the program strengthened inspection readiness, improved operational efficiency and supported patient safety throughout the product lifecycle while helping the sponsor navigate a rapidly changing global regulatory environment. ",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-08/regulatory-intelligence-transforming-compliance-strategy.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-08-26",
"dateModified": "2025-08-26",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-08/regulatory-intelligence-transforming-compliance-strategy.pdf",
"encodingFormat": "application/pdf"
}
}
]
}